Forester Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-20,930
Closed -$1.66M 57
2016
Q3
$1.66M Buy
20,930
+1,020
+5% +$82.9K 1.55% 27
2016
Q2
$1.66M Buy
19,910
+360
+2% +$31.9K 1.54% 26
2016
Q1
$1.92M Sell
19,550
-40
-0.2% -$3.61K 1.79% 28
2015
Q4
$1.98M Buy
19,590
+440
+2% +$45.8K 1.79% 27
2015
Q3
$1.88M Buy
19,150
+200
+1% +$22.2K 1.73% 28
2015
Q2
$2.22M Buy
18,950
+530
+3% +$57.9K 1.8% 28
2015
Q1
$1.81M Buy
18,420
+3,070
+20% +$312K 1.45% 29
2014
Q4
$1.45M Buy
+15,350
New +$1.59M 1.09% 31

Other funds holding GILD

Forester Capital Management's GILD Position: Q4 2016 in Review

Forester Capital Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 20,930 shares — an estimated $1.66M sold.

Forester Capital Management first reported a position in GILD in Q4 2014 and held it in 8 quarters. The position peaked at $2.22M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Forester Capital Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Forester Capital Management sold 20,930 Gilead Sciences shares in Q4 2016, an estimated $1.66M.
  • Forester Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 8 quarters.
  • Forester Capital Management's Gilead Sciences position peaked at $2.22M in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Forester Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.